Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | A Phase 1b Dose-Escalation Study of Cabozantinib (XL184) Administered Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors |
|---|---|
| Disease/Condition | Colon, Colorectal and Rectal Cancer,Gastrointestinal Cancer,Head and Neck Cancer,Lung Cancer,Prostate Cancer,Solid Tumor,Thyroid Cancer,Kidney Cancer,Metastatic Cancer,Oncology (Medical/Hematologic),Carcinoma |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Sanjay Goel, MD |
| Contact Name | Mohammad Ghalib |
| Contact Email | mhghalib@montefiore.org |
| Protocol Number | 18-06-46-01 |
| Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Medical and Hematologic Oncology - Metastatic |
| Adult, Pediatric, Both | Adult |
